Japan’s Rejection Of Foreign Trial Data Continues To Harry Newcomers

Small and mid-size device companies seeking product approval in Japan will encounter resistance to international trial data, according to Pacific Bridge Medical (PBM) President Ames Gross

More from Archive

More from Medtech Insight